rationale of phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
Published 1 year ago • 147 plays • Length 1:14Download video MP4
Download video MP3
Similar videos
-
1:44
results of the phase iii pcs5 trial of hypofractionated radiotherapy for prostate cancer
-
1:24
the potential of moderately hypofractionated radiotherapy: analysis & future directions
-
2:28
hypofractionated radiotherapy for the management of prostate cancer
-
3:13
phase iii trial of the impact of psma pet/ct in salvage radiotherapy management
-
3:00
phase ii randomized trial of conventional vs hypofractionated post-mastectomy proton radiotherapy
-
3:38
results of 5 year phase iii randomised trial treating localised prostate cancer
-
1:15
impact of clinical implementation of hypofractionated radiotherapy on patient quality of life
-
1:28
dr. yu on trials of moderate hypofractionation in prostate cancer
-
3:47
what is hypofractionation in radiation for #prostatecancer? | #markmoyadmd #amarkishanmd | #pcri
-
3:03
randomized phase ii trial of salvage radiotherapy for prostate cancer in 4 weeks v 2 weeks (shorter)
-
11:26
the future of radiotherapy for prostate cancer
-
1:24
2-year toxicity update in pace-b for localised prostate cancer
-
0:56
breakthroughs in prostate cancer treatment
-
0:43
prevalence of severe side effects in the pace-b trial
-
1:58
stereotactic body radiotherapy for prostate cancer
-
2:11
updates in radiotherapy for prostate cancer
-
1:40
prostate cancer clinical trial nrg-gu010 (part 1/3)
-
1:26
bridget f. koontz, md, on moderate hypofractionation & ultra-hypofractionation in prostate cancer
-
1:19
significance of a phase iii study on docetaxel with hormonal & radiation therapy in prostate cancer